Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated potassium channels
Data files
Jan 20, 2025 version files 505.39 KB
-
Figure_1D__E_-_Kv7.4_100_uM_3-Methoxycatechol_-_IV.xlsx
30.13 KB
-
Figure_1D__E_-_Kv7.4_7.5_100_uM_3-Methoxycatechol_-_IV.xlsx
28.99 KB
-
Figure_1D__E_-_Kv7.5_100_uM_3-Methoxycatechol_-_IV.xlsx
29.19 KB
-
Figure_1F_-_Kv7.4_100_uM_3-Methoxycatechol_-_Gmax.xlsx
35.86 KB
-
Figure_1F_-_Kv7.4_7.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
32.71 KB
-
Figure_1F_-_Kv7.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
33.45 KB
-
Figure_1G_-_Kv7.4__Kv7.5__Kv7.4_Kv7.5_100_uM_3-Methoxycatechol_-_RMP.xlsx
9.94 KB
-
Figure_1H__I_-_Kv1.1_100_uM_3-Methoxycatechol_-_IV.xlsx
30.41 KB
-
Figure_1H__I_-_Kv1.2_100_uM_3-Methoxycatechol_-_IV.xlsx
29.95 KB
-
Figure_1H__I_-_Kv1.5_100_uM_3-Methoxycatechol_-_IV.xlsx
27.68 KB
-
Figure_1H__I_-_Kv2.1_100_uM_3-Methoxycatechol_-_IV.xlsx
29.32 KB
-
Figure_1J_-_Kv1.1_100_uM_3-Methoxycatechol_-_Gmax.xlsx
36.76 KB
-
Figure_1J_-_Kv1.2_100_uM_3-Methoxycatechol_-_Gmax.xlsx
35.72 KB
-
Figure_1J_-_Kv1.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
31.83 KB
-
Figure_1J_-_Kv2.1_100_uM_3-Methoxycatechol_-_Gmax.xlsx
34.64 KB
-
Figure_1K_-_Kv1.1__Kv1.2__Kv1.5__Kv2.1_100_uM_3-Methoxycatechol_-_RMP.xlsx
10.07 KB
-
Figure_2A__B__C__D_-_Myography_-_3-methoxycatechol__Linopirdine__BIBN.xlsx
34.76 KB
-
README.md
3.96 KB
Feb 10, 2025 version files 507.10 KB
-
Figure_1D__E_-_Kv7.4_100_uM_3-Methoxycatechol_-_IV.xlsx
30.13 KB
-
Figure_1D__E_-_Kv7.4_7.5_100_uM_3-Methoxycatechol_-_IV.xlsx
29.58 KB
-
Figure_1D__E_-_Kv7.5_100_uM_3-Methoxycatechol_-_IV.xlsx
29.19 KB
-
Figure_1F_-_Kv7.4_100_uM_3-Methoxycatechol_-_Gmax.xlsx
35.86 KB
-
Figure_1F_-_Kv7.4_7.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
33.72 KB
-
Figure_1F_-_Kv7.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
33.45 KB
-
Figure_1G_-_Kv7.4__Kv7.5__Kv7.4_Kv7.5_100_uM_3-Methoxycatechol_-_RMP.xlsx
9.94 KB
-
Figure_1H__I_-_Kv1.1_100_uM_3-Methoxycatechol_-_IV.xlsx
30.41 KB
-
Figure_1H__I_-_Kv1.2_100_uM_3-Methoxycatechol_-_IV.xlsx
29.95 KB
-
Figure_1H__I_-_Kv1.5_100_uM_3-Methoxycatechol_-_IV.xlsx
27.68 KB
-
Figure_1H__I_-_Kv2.1_100_uM_3-Methoxycatechol_-_IV.xlsx
29.32 KB
-
Figure_1J_-_Kv1.1_100_uM_3-Methoxycatechol_-_Gmax.xlsx
36.76 KB
-
Figure_1J_-_Kv1.2_100_uM_3-Methoxycatechol_-_Gmax.xlsx
35.72 KB
-
Figure_1J_-_Kv1.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
31.83 KB
-
Figure_1J_-_Kv2.1_100_uM_3-Methoxycatechol_-_Gmax.xlsx
34.64 KB
-
Figure_1K_-_Kv1.1__Kv1.2__Kv1.5__Kv2.1_100_uM_3-Methoxycatechol_-_RMP.xlsx
10.07 KB
-
Figure_2A__B__C__D_-_Myography_-_3-methoxycatechol__Linopirdine__BIBN.xlsx
34.76 KB
-
README.md
4.07 KB
Feb 12, 2025 version files 444.27 KB
-
Figure_1D__E_-_Kv7.4_100_uM_3-Methoxycatechol_-_IV.xlsx
25.81 KB
-
Figure_1D__E_-_Kv7.4_7.5_100_uM_3-Methoxycatechol_-_IV.xlsx
25.03 KB
-
Figure_1D__E_-_Kv7.5_100_uM_3-Methoxycatechol_-_IV.xlsx
24.64 KB
-
Figure_1F_-_Kv7.4_100_uM_3-Methoxycatechol_-_Gmax.xlsx
31.12 KB
-
Figure_1F_-_Kv7.4_7.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
28.94 KB
-
Figure_1F_-_Kv7.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
28.65 KB
-
Figure_1G_-_Kv7.4__Kv7.5__Kv7.4_Kv7.5_100_uM_3-Methoxycatechol_-_RMP.xlsx
9.94 KB
-
Figure_1H__I_-_Kv1.1_100_uM_3-Methoxycatechol_-_IV.xlsx
26.09 KB
-
Figure_1H__I_-_Kv1.2_100_uM_3-Methoxycatechol_-_IV.xlsx
25.61 KB
-
Figure_1H__I_-_Kv1.5_100_uM_3-Methoxycatechol_-_IV.xlsx
23.34 KB
-
Figure_1H__I_-_Kv2.1_100_uM_3-Methoxycatechol_-_IV.xlsx
24.97 KB
-
Figure_1J_-_Kv1.1_100_uM_3-Methoxycatechol_-_Gmax.xlsx
32.42 KB
-
Figure_1J_-_Kv1.2_100_uM_3-Methoxycatechol_-_Gmax.xlsx
31.37 KB
-
Figure_1J_-_Kv1.5_100_uM_3-Methoxycatechol_-_Gmax.xlsx
27.03 KB
-
Figure_1J_-_Kv2.1_100_uM_3-Methoxycatechol_-_Gmax.xlsx
30.34 KB
-
Figure_1K_-_Kv1.1__Kv1.2__Kv1.5__Kv2.1_100_uM_3-Methoxycatechol_-_RMP.xlsx
10.07 KB
-
Figure_2A__B__C__D_-_Myography_-_3-methoxycatechol__Linopirdine__BIBN.xlsx
34.66 KB
-
README.md
4.23 KB
Abstract
The Kv7 (KCNQ) family of voltage-gated potassium (Kv) channels comprises Kv7.1-7.5, which are expressed throughout the human body where they regulate numerous essential physiological processes . As such, there has been a lot of interest in developing and identifying small molecules that can modulate specific Kv7 channel isoforms. We previously discovered that plant metabolites such as aloperine from Sophora flavescens (Ku Shen), carnosol and carnosic acid from rosemary (Salvia rosmarinus), and gallic acid and tannic acid from Native American bark extracts are efficacious Kv7.5 channel activators with prominent vasorelaxant effects. Kv7.1, Kv7.4, and Kv7.5 channels are important regulators of smooth muscle contractility, regulating the membrane potential of vascular smooth muscle and subsequently vascular tone. Pharmacological targeting of these Kv7 channels with pan-Kv7 inhibitors XE-991 and linopirdine provokes membrane depolarization and vasoconstriction, while several structurally disparate activators enhance Kv7 channel currents resulting in membrane hyperpolarization and vasorelaxation. Recently, it was concluded based in ex vivo pharmacology and in silico docking that the vasorelaxant effects of 3-methoxycatechol (3-MOC) arise from direct binding to and activation of Kv channels in the vascular smooth muscle, specifically Kv7.4, but the direct effects on Kv channels were not substantiated experimentally. Here, we report that the mechanism of vasodilation by 3-MOC is not via direct Kv channel activation and strongly advise against pharmacological target assumptions using non-experimentally validated in silico docking, a technique not appropriate for this purpose.
README
Source Data for manuscript: Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated
potassium channels
The datasets included are the original Excel files used to generate each panel for figures 1 and 2 in this manuscript. The title of each Excel file is labeled to directly correspond to the figure in the manuscript:
Figure Number & panel > Channel Investigated > Condition > Parameter Measured
The data contained within this repository are those obtained from cellular electrophysiology recordings. We used two-electrode voltage clamp (TEVC) electrophysiology and the Xenopus laevis oocyte expression system to record the electrical activity of wild-type Kv7.4, Kv7.5, Kv7.4/7.5, Kv1.1, Kv1.2, Kv1.5, and Kv2.1 channels in response to 100 uM 3-methoxycatechol. Xenopus laevis oocytes were injected with cRNA encoding for each of these channels and were incubated at 16 degrees for 1-4 days prior to recording using TEVC. The subsequent measurements allow us to characterize the biophysical responses of these channels to 3-methoxycatechol.
Additionally, this study also used mesenteric artery myography to elucidate the molecular mechanism of action of 3-methoxycatechol. The technique measures the force of contraction and relaxation of ex-vivo mesenteric arteries in response to various stimuli. In this study the artery segments were precontracted with methoxamine in the absence or presence of ion channel and receptor specific inhibitors, before application of 3-methoxycatechol.
The parameters that we measured to characterize the effect of 3-methoxycatechol on Kv7.4, Kv7.5, Kv7.4/7.5, Kv1.1, Kv1.2, Kv1.5, and Kv2.1 channels as well as mesenteric artery are as follows:
Current-voltage (IV) curve
This is a graph representing the relationship between the electrical current (flow of ions) and voltage applied across a device (the cell membrane). In electrophysiology, I-V curves are used to study the activity of biological cells, in this case Xenopus oocytes expressing the aforementioned channels. The data contained in these excel files were measured from the peak of the prepulse current generated by a voltage protocol that starts at a holding potential of -80 mV and increases in +10 mV increments until +40 mV. All raw values are in microamps (uA).Gmax
These data were used to generate conductance-voltage curves. Graphs were generated by taking measurements from the tail current (recorded at -30 or -40 mV) immediately following the prepulse current as described above. These data enable us to determine the shift in voltage-dependence of activation of the channel in response to 3-methoxycatechol. Raw values are in microamps (uA).Resting membrane potential
The resting membrane potential (RMP) is the electrical potential difference across a cell's membrane at rest. The RMP is determined by the concentration of ions across the membrane and the membrane permeability to each type of ion. Kv channels expressed in Xenopus oocytes whose activity is augmented pharmacologically will result in a hyperpolarizing shift in the RMP. Here, we measured the RMP (EM) of unclamped Xenopus laevis oocytes expressing the aforementioned channels and reported the values in millivolts (mV).Mesenteric artery myography
The data collected for this analysis was obtained from mesenteric arteries from adult male rats pre-contracted with methoxamine (10 µM) in the absence or presence of 10 µM linopirdine (Kv7-specific antagonist) or 100 nM BIBN-4096 (CGRP receptor-specific antagonist), before application of 3-methoxycatechol (0.01, 0.03, 0.1, 1, 3, 10, 30, and 100 µM). Raw values are in milli-newton (mN).Statistics
All statistical analysis were conducted as either paired t-test.Additional Information
Excel files with cells with 'n.a.' means not applicable. No data was obtained for this cell.Version changes
10-Feb-2025: IV and Gmax graphs for Kv7.4/7.5 were updated to the versions used to generate the data in the published manuscript.11-Feb-2025: IV, Gmax, and Mesenteric artery myography Excel files have been updated after a typo was identified. This has now been resolved.
Methods
cRNA prepeartion and Two-electrode voltage clamp (TEVC)
cRNA transcripts encoding human Kv7.4, Kv7.5, Kv1.1, Kv1.2, Kv1.5, and Kv2.1 were generated by in vitro transcription using the mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization, from cDNA sub-cloned into plasmids incorporating Xenopus laevis β-globin 5’ and 3’ UTRs flanking the coding region to enhance translation and cRNA stability. Defolliculated stage V and VI Xenopus laevis oocytes (Xenoocyte, Dexter, MI, US) were injected with KCNQ cRNAs (0.1-25 ng) and incubated at 16 oC in ND96 oocyte storage solution containing penicillin and streptomycin, with daily washing, for 1-4 days prior to two-electrode voltage-clamp (TEVC) recording.TEVC was performed at room temperature using an OC-725C amplifier (Warner Instruments, Hamden, CT) and pClamp10 software (Molecular Devices, Sunnyvale, CA) 1-4 days after cRNA injection as described in the section above. For recording, oocytes were placed in a small-volume oocyte bath (Warner) and viewed with a dissection microscope. 3-methoxycatechol was sourced from Sigma and made into 250 mM stock solutions in DMSO prior to dilution in recording solution (in mM): 96 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES (pH 7.6). 3-methoxycatechol was introduced into the oocyte recording bath by gravity perfusion at a constant flow of 1 ml per minute for 3 minutes prior to recording. Pipettes were of 1-2 MΩ resistance when filled with 3 M KCl. Currents were recorded in response to voltage pulses between -80 mV and +40 mV at 10 mV intervals from a holding potential of -80 mV, to yield current-voltage relationships and examine activation kinetics. Data was analyzed using Clampfit (Molecular Devices) and Graphpad Prism software (GraphPad, San Diego, CA, USA), stating values as mean ± SEM. Raw or normalized tail currents were plotted versus prepulse voltage and fitted with a single Boltzmann function.
Mesenteric artery myography
In accordance with the methods of killing animals described in annex IV of the EU Directive 2010/63EU on the protection of animals used for scientific purposes, male wistar rats, 12 weeks old (Janvier Labs, France), were made unconscious by a single, percussive blow to the head. Immediately after the onset of unconsciousness, cervical dislocation was performed. Rats were group-housed with regular 12-hour light/dark cycles, in clear plastic containers with ad libitum access to food and water and underwent at least one week of habituation. After euthanasia, the intestines were removed, and third-order mesenteric arteries were dissected in ice-cold physiological saline solution containing (in mM): 121 NaCl, 2.8 KCl, 1.6 CaCl2, 25 NaHCO3, 1.2 KH2HPO4, 1.2 MgSO4, 0.03 EDTA, and 5.5 glucose. Segments, 2 mm in length, of mesenteric artery were mounted on 40 µm stainless steel wires in a myograph (Danish Myo Technology, Aarhus, Denmark) for isometric tension recordings. The chambers of the myograph contained PSS maintained at 37°C and aerated with 95% O2/5% CO2. Changes in tension were recorded by PowerLab and Chart software (ADInstruments, Oxford, United Kingdom). The arteries were equilibrated for 30 minutes and normalized to passive force. Artery segments were precontracted with 10 µM methoxamine (Sigma; Copenhagen, Denmark) in the absence or presence of linopirdine (10 µM) and BIBN-4096 (100 nM) (Sigma; Copenhagen, Denmark), before application of 3-methoxycatechol at logarithmic concentrations.
Statistics and Reproducibility
All values are expressed as mean ± SEM. One-way ANOVA was applied for all tests; all p values were two-sided.